The in vitro effects of thrombomodulin on the inactivation of single chain urokinase-type plasminogen activator (scu-PA) by thrombin were investigated by incubating scu-PA with varying concentrations of human thrombin, in both the absence and presence of soluble rabbit thrombomodulin. 50% inactivation of scu-PA occurred in 45 min at 160 ng/ml thrombin in the absence of thrombomodulin and at 4.6 ng/ml thrombin in the presence of thrombomodulin. No difference was found in either the absence or the presence of thrombomodulin between the inactivation rates of high molecular weight scu-PA, and a low molecular weight scu-PA which lacked the growth factor and kringle domains. Enzyme kinetic experiments with varying concentrations of scu-PA showed that thrombomodulin decreased the K. of thrombin for scu-PA from 7.8 to 0.43 p&M and increased the kli from 0.30 to 1.2 s-1, corresponding to a 70-fold increase in the second-order rate constant k,/JK. SDSpolyacrylamide gel electrophoresis showed that scu-PA was cleaved into two chains upon inactivation by thrombin, and confirmed the acceleration effect of thrombomodulin on inactivation of scu-PA. Thrombomodulin thus not only has anticoagulant properties but is also antifibrinolytic. The acceleration may imply a new mechanism for the regulation of local plasminogen activator activity on the cell surface. (J. Clin. Invest.
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tivator (u-PA) are successfully applied for fibrinolytic therapy, it is not yet known whether u-PA plays an important role in endogenous fibrinolysis. On the other hand, scu-PA probably does play a role in cell migration, tissue destruction and tissue remodeling (for review, see 4). Both scu-PA and tcu-PA have 50,000 M,; tcu-PA consists of two chains with M, 20 ,000 and 30,000, held together by a disulfide bridge (5) . In certain cell cultures a low molecular weight (LMW) form of scu-PA with M, 32 ,000 occurs (6, 7) that lacks the NH2-terminal part (the epidermal growth factor domain and the kringle domain) ofthe high molecularweight (HMW) form ofscu-PA. No significant difference has yet been found between the thrombolytic properties of LMW scu-PA and HMW scu-PA (8, 9) .
The single chain form of u-PA can be converted to active tcu-PA by hydrolysis of the Lys 1 58-Ile 159 peptide bond by plasmin (10) , plasma kallikrein (11, 12) , Factor XII (11) , and trypsin (13) . Thrombin hydrolyses scu-PA at the Arg 1 56-Phe 157 bond, leading to an inactive tcu-PA (11, 14, 15) , which is much less sensitive to activation with plasmin (16) .
Thrombomodulin is a membrane protein of endothelial cells, which forms a 1:1 complex with thrombin (17) and stimulates the anticoagulant properties of thrombin by accelerating the activation of protein C (18), (for reviews, see [19] [20] [21] [22] .
The aims of this study were to investigate the effect of thrombomodulin on the inactivation of scu-PA by thrombin and to compare the inactivation by thrombin of HMW and LMW scu-PA. We found that thrombomodulin strongly accelerated the inactivation of both HMW and LMW scu-PA by thrombin.
Methods
Materials. Both HMW scu-PA and LMW scu-PA, purified from human embryonic kidney cell cultures (23) , were donated by Dr J. Henkin, Abbott Laboratories (Abbott Park, IL). Rabbit lung thrombomodulin and goat anti-rabbit thrombomodulin IgG were purchased from American Diagnostica Inc. (Greenwich, CT). Hirudin was from Pentapharm (Basel, Switzerland). Goat non-immune IgG was isolated by two sodium sulfate precipitations (24) . Human plasmin and chromogenic substrate Pyro-Glu-Gly-Arg-pNA (S-2444) were ,ug/ml thrombomodulin (13.5 nM) for S min at 370C immediately before each experiment. Functional activity of the thrombomodulin preparation was demonstrated by inhibition of the fibrinogen-clotting activity of thrombin by thrombomodulin, tested as described by Esmon et al. (17) .
Inactivation ofscu-PA. The principle ofthe assay for scu-PA inactivation has been described (15). During 45 min at 370C, 240 ng/ml HMW or LMW scu-PA was incubated with 0-0.6 ,g/ml thrombin or with 0-0.3 ug/ml thrombin after pre-incubation with 1 /sg/ml thrombomodulin, in 20 mM Tris/HCI, pH 7.5, 100 mM NaCl, 3 mM CaCl2, 0.1% BSA, and 0.1% Tween 80. The inactivation was stopped by diluting the mixture in cold hirudin-containing dilution buffer of the assay for scu-PA. In another experiment, varying concentrations of thrombomodulin (0-1 ug/ml) were pre-incubated with 15 ng/ml thrombin before 240 ng/ml HMW scu-PA was added. After 45 min at 37°C, the inactivation was stopped and remaining scu-PA was assayed.
Goat anti-rabbit thrombomodulin IgG (40 ,g/ml) or goat non-immune IgG (40 ,ug/ml) was incubated at 37°C for 5 min with 50 ng/ml thrombomodulin. After thrombin was added (15 ng/ml final concentration) and incubated again at 37°C for 5 min, HMW scu-PA (240 ng/ml final concentration) was added and incubated at 37°C for 45 min. Remaining scu-PA was measured.
The effect of Ca2+ on the inactivation of 240 ng/ml HMW scu-PA was studied by adding 0-0.60 ,g/ml thrombin alone, or 0-0.12 ,g/ml thrombin after incubation with 1 ug/ml thrombomodulin, both in the presence and in the absence of 3 mM CaCl2. After incubation at 37°C for 45 min, remaining scu-PA was assayed.
Kinetic experiments. Concentrations of HMW scu-PA ranging from 0.05 to 4gM were incubated with 4 nM (150 ng/ml) thrombin or 0.04 nM (1.5 ng/ml) thrombin after preincubation with 1 gg/ml thrombomodulin in 20 mM Tris/HCl, pH 7.5, 100 mM NaCl, 3 mM CaC12, 0.1% Tween 80, and 0.1% BSA at 37°C. At intervals ofO, 15, 30, 45 and 60 min, aliquots were taken and the reaction was stopped as described above. Remaining scu-PA was measured with S-2444 after activation with plasmin and the initial rates of scu-PA inactivation were determined from the linear parts of the time curves.
SDS-polyacrylamide gel electrophoresis. SDS-PAGE was performed according to the method of Laemmli (25) , using a 12% polyacrylamide gel. Samples of 30 Al were diluted 1:1 in sample buffer containing 4% (wt/vol) SDS, 20% (wt/vol) glycerol, 0.005% (wt/vol) bromophenol blue and 4% (wt/vol) 2-mercaptoethanol in 125 mM Tris/HCl, pH 6.8 and incubated for 5 min at 100°C. A calibration kit with standard proteins was obtained from Pharmacia LKB Biotechnology (Uppsala, Sweden).
Results
Inactivation ofHMWand LMWscu-PA. To study the effect of thrombomodulin on the inactivation of scu-PA by thrombin, 240 ng/ml HMW and LMW scu-PA were incubated for 45 min at 37°C with varying amounts ofthrombin, both in the absence and presence of 1 gg/ml thrombomodulin. Remaining scu-PA, not inactivated by thrombin, was activated with plasmin and quantified using S-2444. 50% of scu-PA was inactivated by 160±41 ng/ml (mean±SD, n = 5) thrombin in the absence of thrombomodulin or by only 4.6±1.4 (n = 4) ng/ml thrombin in the presence ofthrombomodulin (Fig. 1) . No difference was found in the relative inactivation rate between LMW scu-PA and HMW scu-PA, either in the absence or in the presence of thrombomodulin. Fig. 2 shows that remaining scu-PA gradually decreased at increasing thrombomodulin concentrations and a fixed throm- The neutralizing effect of goat antibodies against thrombomodulin was studied in Fig. 3 . Approximately 4% scu-PA was inactivated by 15 ng/ml thrombin alone, whereas 56% was inactivated by the same concentration thrombin complexed with 50 ng/ml thrombomodulin. The antibodies almost completely quenched the accelerating effect of thrombomodulin on the inactivation of HMW scu-PA, whereas goat non-immune IgG had only a minor effect.
SDS-PAGE ofinactivatedHMWandLMWscu-PA. HMW and LMW scu-PA were incubated with a low concentration of thrombin (75 ng/ml), both with and without 1 ,ug/ml thrombomodulin, or with a high concentration ofthrombin (1.2 ,gg/ml), and subjected to SDS-PAGE (Fig. 4) . The low concentration of thrombin partially cleaved HMW scu-PA into two subunits: one of M, 32,000 and one of Mr 20,000 or 22,000 (lane 3). In contrast, the thrombin-thrombomodulin complex completely cleaved HMW scu-PA (lane 4), as did the high concentration of thrombin (lane 5). Comparison of the extent of cleavage in lanes 3 and 4 clearly shows the accelerating effect of thrombomodulin. As expected, inactivation of LMW scu-PA did not lead to a significant shift ofthe protein band, because a peptide of only 13 amino acids was supposed to be cut off.
Kinetics of the inactivation of HMW scu-PA. Varying amounts of HMW scu-PA were incubated with thrombin or with thrombin after preincubation with excess thrombomodulin. Kinetic analysis shows that the inactivation rate of scu-PA by both thrombin and the thrombin-thrombomodulin complex obeyed Michaelis-Menten kinetics. Using LineweaverBurk plots (Fig. 5) , the Km and ka,, were determined to be 7.8 ,uM and 0.30 s-', respectively, in the case ofthrombin and 0.43 ,4M and 1.2 s-', respectively, for the thrombin-thrombomodulin complex (Table I ). The second-order rate constant (kmJ/Km) of thrombin increased from 0.039 to 2.7 ,uM-' * s-1 (70 times) by complex formation with thrombomodulin.
Effect of Ca2" on the inactivation ofHMW scu-PA. In the presence of Ca2" more thrombin was required to inactivate HMW scu-PA than in the absence of Ca2". This was observed both in the presence (23 times more thrombin to achieve 50% inactivation) and in the absence (9 times more) of thrombomodulin (Fig. 6 ). An experiment with varying Ca2" concentrations (0-6 mM) revealed that under both conditions a plateau was reached at 3 mM Ca2" (not shown with 15 ng/ml thrombin preincubated in 50 ng/ ml thrombomodulin (2), and with 15 ng/ml thrombin, 50 ng/ml thrombomodulin, and 40 ,gg/ml goat non-immune IgG (3) thrombin. This finding was supported by the following observations: (a) The effect ofthrombomodulin was dose dependent and corresponded with an apparent Kd for the thrombinthrombomodulin complex of0.57 nM, which is very similar to previously reported values of 0.48 and 0.54 nM (18, 29) . (b) Goat anti-rabbit thrombomodulin IgG inhibited the accelerating effect of thrombomodulin. (c) The action ofthrombomodulin accompanied the conversion of scu-PA into a tcu-PA that was indistinguishable on SDS-PAGE from the tcu-PA formed by a high concentration of thrombin. The inactivation ofHMW scu-PA by the thrombin-thrombomodulin complex as well as by thrombin alone obeyed Michaelis-Menten kinetics. The k,/Km for thrombin alone was 0.039 ,M-' * s-' and increased 70-fold to 2.7 uM-' -s-' for the thrombin-thrombomodulin complex. It is difficult to establish whether the latter rate constant is high enough to be significant in vivo. However, the rate constant is of the same order of magnitude as that for the activation of scu-PA by plasmin (30, 31) . In addition, the k,,J/Km for the activation of protein C by the thrombin-thrombomodulin complex in an assay system as used in this study is 0.81 tM-' -s-' (27) , which is also of the same order of magnitude (Table I ). The activation rate of protein C by the complex further increases on cell surfaces and in the presence of phospholipids ( 18, 28) . It still has to be determined whether the inactivation rate of scu-PA on cell surfaces is higher than in the solubilized system.
In the absence of endothelial cells, Ca2+ reduces the rate of protein C activation by thrombin, but stimulates the activation rate by the thrombin-thrombomodulin complex (32) . The thrombin-thrombomodulin interaction is Ca2" independent ( 17) . In contrast to the diverging effects of Ca2+ on protein C . Lineweaver-I At varying concentrati4 bin (A) and thrombin measured as described determined by using th in Table I. activation, Ca2+ redi thrombin and throm yet clear whether th whether the substral known Ca2+-binding
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